Praxis Precision Medicines

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PRAX and other ETFs, options, and stocks.

About PRAX

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus.

CEO

Marcio Souza

CEOMarcio Souza

Employees

116

Employees116

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2015

Founded2015

Employees

116

Employees116

PRAX Key Statistics

Market cap

879.53M

Market cap879.53M

Price-Earnings ratio

-4.03

Price-Earnings ratio-4.03

Dividend yield

—

Dividend yield—

Average volume

279.73K

Average volume279.73K

High today

—

High today—

Low today

—

Low today—

Open price

$41.88

Open price$41.88

Volume

0.00

Volume0.00

52 Week high

$91.83

52 Week high$91.83

52 Week low

$26.70

52 Week low$26.70

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

Sell

8.3%

People also own

Based on the portfolios of people who own PRAX. This list is generated using Robinhood data, and it’s not a recommendation.